What is Stargardt Disease? What are its Symptoms? How is it Diagnosed and Treated?

Stargardt Disease is an inherited eye disorder that primarily causes central vision loss, especially in young individuals. This condition typically emerges during adolescence and complicates daily activities that require detailed vision, such as reading books and recognizing faces. Therefore, early diagnosis and the right approach can significantly impact your quality of life.

In this article, you will find everything you need to know about what Stargardt disease is, its symptoms, causes, and treatment options. We will also provide detailed information about diagnostic methods and current research.

What is Stargardt Disease?

Stargardt disease is the most common macular disorder among hereditary eye diseases, accounting for approximately 7% of all retinal disorders. This condition is transmitted from parents to child through an autosomal recessive inheritance pattern.

Mutations in the ABCA4 gene are the primary cause of Stargardt eye disease. This gene is responsible for the removal of waste products from the retinal pigment layer at the back of the eye. However, due to the genetic disorder, this cleaning process is disrupted, leading to the accumulation of harmful substances in the retina.

If both parents carry this gene mutation, it can be passed on to the child. Therefore, it is classified among rare hereditary diseases. Transmission to children can occur even before symptoms appear in the parents.

Effects of the Disease on the Retina

Stargardt disease directly affects the macula, the central part of the retina. The macula is the area that provides sharp vision and detail perception. Damage in this area leads to difficulties in activities such as reading and recognizing faces.

As the disease progresses, the light-sensitive photoreceptor cells become damaged and begin to die. Consequently, central vision clarity decreases. However, peripheral vision is generally preserved. This condition does not lead to complete blindness but affects only the central visual field.

Yellow-white spots appear in the retina, particularly concentrated in the macula and posterior pole. Over time, these spots surrounding the central atrophy areas merge to create a typical “beaten copper appearance”.

Lipofuscin Accumulation and Macular Degeneration

The underlying cause of Stargardt disease is the accumulation of a brown pigment called lipofuscin. This substance is a fatty yellow waste product found in the eye. Under normal conditions, your body cleanses these wastes, but the ABCA4 gene mutation impedes this cleaning process.

Lipofuscin accumulates in the retinal pigment epithelium (RPE) and gradually damages the cells. The accumulation of this substance on the macula leads to restricted vision. Additionally, this accumulation causes a characteristic “dark choroid” appearance during fundus examination.

As a result, atrophic degeneration in the macula shows a progressive course. This toxic accumulation in retinal cells obstructs visual transmission, leading to a loss of clarity. The severity of the disease and the rate of progression can vary from person to person.

What are the Symptoms of Stargardt Disease?

Symptoms of Stargardt disease typically manifest during childhood or adolescence. As damage to the retinal cells increases, significant impairments in vision occur. The initial symptoms often present as disturbances in central vision, difficulties seeing in low light, and changes in color perception.

Loss of Central Vision

The most common symptom in Stargardt disease is the loss of central vision. In some patients, this condition progresses more rapidly, while in others, it progresses more slowly. Loss of central vision is a significant symptom that reduces the ability to see clearly and in detail.

The emergence of gray, black, or blurry areas in the central visual field is a typical finding. This condition particularly complicates daily activities such as reading, driving, and recognizing faces. The visual center becoming increasingly less functional makes it difficult to read text and watch screens.

Blurry Vision and Decreased Visual Acuity

Stargardt disease causes vision loss ranging from 20/50 to 20/200 on a standard eye chart. Fluctuations in the visual field, blurriness, or spots may be observed. The person may continuously open and close their eyes in an attempt to clarify their surroundings.

Damage to the macula leads to blurriness and loss of focus over time. You may experience difficulty in recognizing familiar faces. The degeneration that occurs with the progression of the disease severely affects visual quality.

Photophobia (Light Sensitivity)

Photophobia is defined as an excessive sensitivity to light. In Stargardt patients, this condition may manifest as discomfort and glare in outdoor lighting. You will experience more vision loss under bright light.

Therefore, photophobia may cause you to avoid bright areas over time. Sensitivity to light negatively affects daily life.

Disturbances in Color Perception

Damage to the retina can also negatively affect the perception of colors. It becomes increasingly difficult to distinguish between shades. Perceiving colors as pale or in different tones is a common symptom.

The ability to differentiate colors decreases over time. In the later stages of Stargardt disease, the ability to see colors may also be lost. Such color vision problems make it difficult for patients to distinguish objects in daily life.

Night Blindness and Dark Adaptation

An extended adaptation period to dark and light environments is among the symptoms of Stargardt disease. Vision loss becomes more pronounced, especially in low light conditions. You will have difficulty adapting to changes in light in the environment.

You may experience difficulties seeing in low light or darkness. The inability to distinguish figures in dim light may occur.

What Causes Stargardt Disease?

Genetic factors are the primary answer to the question of what causes Stargardt disease. Disorders in the ABCA4 gene trigger this visual disorder. Genetic transmission from parents plays a decisive role in the emergence of the disease.

ABCA4 Gene and Genetic Mutations

The ABCA4 gene produces a protein responsible for cleaning waste products accumulated in the retinal cells of your eye. This gene also regulates the use of vitamin A in the body. When the gene does not function properly, the cleaning process is disrupted, leading to harmful accumulations in the macula.

Scientists have discovered over 1500 different mutations in the ABCA4 gene. Each mutation leads to varying degrees of protein dysfunction. Therefore, the severity of the disease and the rate of progression can vary from person to person. Some patients experience rapid vision loss, while others may have a slower course.

When this gene mutates, it causes the accumulation of a toxic compound called lipofuscin in retinal cells. Cells responsible for protein production do not function properly. Thus, waste product cleaning does not occur, leading to visual disorders.

Inheritance Pattern

Stargardt eye disease is mostly inherited through autosomal recessive inheritance. This means that to develop the disease, you must inherit the faulty ABCA4 gene from both your mother and father. If both parents have this gene mutation, it can be passed on to the child.

The disease manifests in the child through genes passed from carrier parents. Even if there are no symptoms in the parents, gene carrier status may exist. This situation is more frequently observed in consanguineous marriages. Individuals with a family history are considered at high risk.

The prevalence of the disease is about 1 in 8,000 to 10,000 people. Therefore, it is classified among rare hereditary diseases. Genetic predisposition is another factor. Rarely, Stargardt disease may occur in individuals due to genetic makeup even without the disease being present in the parents.

Vitamin A Metabolism and Toxic Accumulation

Vitamin A is a nutrient that is heavily utilized in the retina. The layer of light-sensitive cells at the back of your eye continuously benefits from this vitamin. After retinal cells use vitamin A, they produce fatty waste products.

Under normal conditions, the protein produced by the ABCA4 gene cleans these wastes. However, in Stargardt disease, the gene does not function properly. As a result, yellowish accumulations form in the macula. These accumulations eventually lead to cell damage and deterioration of central vision.

Imbalances in vitamin A metabolism affect the progression of the process. When the cleaning of waste products in retinal cells is hindered, toxic pigments accumulate. This accumulation leads to the death of retinal cells and vision loss. In rare cases, individuals with congenital vitamin A excess may also develop the disease.

How is Stargardt Disease Diagnosed?

When you experience a decrease in visual acuity, a detailed evaluation process is initiated by an eye disease specialist. The diagnosis of Stargardt disease begins with a comprehensive clinical examination. In the first stage, a physical examination is performed, and your health history is taken. The family history of eye diseases is also questioned during this process.

Fundus Examination and Clinical Findings

During the fundus examination, changes in the retinal layer are examined. The doctor looks for yellow-white spots in the macula using special instruments. The presence of small yellowish spots indicative of damaged tissue in the retinal pigment epithelium is crucial for diagnosis.

Yellowish lipofuscin accumulation and imbalances around the macula are the earliest signs of the disease. These characteristic changes become visible. Fundus photography captures images of the retina and macula region, revealing lipofuscin accumulations in the retina.

Fluorescein angiography is used to examine the structure of retinal vessels. This technique allows detailed visualization of vascular structures. Additionally, fundus autofluorescence imaging is beneficial in diagnosing and monitoring the disease.

Fundus Autofluorescence and OCT Imaging

Fundus autofluorescence imaging helps understand the pathology in macular and retinal dystrophies. This method shows different autofluorescence signals. Abnormal autofluorescence distribution may contribute to diagnosis even before clear symptoms appear.

Optical coherence tomography (OCT) provides detailed imaging of the layers of the retina. OCT, as a non-invasive technique, reveals the structure of the retina with millimeter precision. Disruptions in the macula region can be clearly identified this way. The data is valuable for monitoring the disease’s progression and creating personalized follow-up plans.

Electroretinography (ERG) Test

Electroretinography measures the electrical responses of retinal cells to light. The retina’s response to light stimuli is assessed. ERG helps identify damaged cells. This test plays a critical role in evaluating retinal function.

Significant changes in ERG findings over time are important for tracking progression. It has been observed that all parameters have regressed from subnormal to pathological levels over a three-year period. Significant reductions in rod, maximal, oscillatory potentials, cone, and flicker responses have been noted.

Genetic Testing and Molecular Diagnosis

Genetic testing can be performed to visualize mutations in the ABCA4 gene. This test is decisive in making a definitive diagnosis of the disease. Molecular analysis results are obtained within 45-60 days. An EDTA blood sample is used for the test.

Genetic tests clarify mutations and reveal carrier status. Risk analysis can be conducted early in individuals with a family history. As a result of all the tests performed, a definitive diagnosis becomes possible.

Treatment and Quality of Life in Stargardt Disease

Supportive Treatment Methods

There is currently no definitive treatment that completely eliminates Stargardt disease. However, supportive approaches aimed at slowing the progression of the disease and preserving visual function are applied. Treatment generally focuses on reducing vision loss and enhancing your quality of life.

Early diagnosis and regular follow-up are crucial in managing the disease. Your eye specialist will prepare a plan tailored to your personal needs. You should avoid smoking. Routine eye examinations help monitor the progression of the disease.

UV Protection and Sunglasses Use

Wearing glasses that protect against UV and blue light is a simple yet effective measure to slow the progression of the disease. Research has shown that exposure to bright light can trigger retinal damage. Therefore, wearing sunglasses that block sunlight prevents further damage to your eyes.

Wide-spectrum sunglasses and hats with brims can be preferred for daily protection. Especially in outdoor environments, you should regularly use sunglasses with UV filters. It is advisable to protect your eyes from sunlight with hats and glasses when you go outside.

Vision Rehabilitation and Optical Aids

Optical aids developed for individuals with low vision make daily activities more accessible. Contrast-enhancing lenses, magnifiers, and electronic imaging systems provide support for living. Vision-friendly lighting also positively affects this process.

Customized optical systems can be used for Stargardt patients:

• Distance vision aids: Monocular telescope, binocular telescope, glasses-type telescope
• Near vision aids: Magnifying glasses, stand magnifiers, handheld magnifiers
• Electronic devices: CCTV systems, computer programs, mobile applications

Simple bifocals can be used in early stages. In advanced stages, CCTV systems may be beneficial.

Nutrition and Vitamin A Restriction

Avoiding excess vitamin A is critically important. It can accelerate vision loss by increasing lipofuscin accumulation in the retina. You should avoid vitamin supplements that may lead to excessive intake beyond the recommended daily amount.

A diet rich in antioxidants can help protect retinal cells. Recent studies have shown that nutrients such as omega-3, lutein, and zeaxanthin are significant in reducing A2E accumulation. Consuming leafy greens, fruits, and fish supports eye health.

Current Research and Gene Therapy

Gene and mRNA therapies aim to correct the ABCA4 mutation. ALK-001 is a drug in the research phase aimed at reducing toxic accumulation in the retina. Tinlarebant is an oral treatment aimed at slowing disease progression and is currently undergoing clinical trials.

RNA editing therapy, optogenetic therapy, complement inhibitor therapy, and gene-modified therapies are also in the research phase. Stem cell, PRP, and exosome therapies aim to slow the progression of the disease. However, all treatments mentioned in this section are still in the research phase and are not yet approved treatments.

Frequently Asked Questions About Stargardt Disease

You may have many questions regarding Stargardt disease. Clarifying the most frequently asked topics will guide you.

In Summary, Stargardt Disease

Stargardt disease is a hereditary eye disorder that leads to central vision loss. Therefore, early diagnosis directly affects your quality of life. Although there is currently no definitive treatment, supportive methods can slow the progression of the disease.

Wear UV-protective glasses, avoid vitamin A supplements, and have regular eye check-ups. Optical aids facilitate your daily activities. Additionally, current research shows promising results.

If you are experiencing vision problems, consult an eye specialist for a detailed examination. With the right approach, you can manage the disease and maintain your quality of life.

Learn about what Stargardt disease is, its symptoms, how it is diagnosed, treatment methods, and recommendations to enhance quality of life.